Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Mirati Therapeutics

Request full access

Biotechnology company located in 9363 towne centre dr, san diego, ca, united states

San Diego, United StatesFounded 2013Biotech & Life Sciences

About Mirati Therapeutics

Mirati Therapeutics is a biotechnology company that operates in the healthcare sector, specifically in the oncology market. The company focuses on developing novel therapeutics for the treatment of cancer. Mirati's primary area of research and development is on RAS proteins, which are often mutated in many types of cancer, including non-small cell lung cancer and pancreatic cancer.

The company's business model revolves around the development of these innovative cancer treatments. Once these treatments have been developed and approved, they are sold to healthcare providers who administer them to patients. The company's revenue is generated from the sales of these treatments.

Mirati's key product in development is a KRAS inhibitor, which is designed to target and inhibit the function of the KRAS protein, a common mutation in many types of cancer. This could potentially provide a new treatment option for patients with these types of cancer, for whom there are currently limited treatment options.

In addition to its KRAS inhibitor, Mirati is also developing a combination therapy of sitravatinib and nivolumab for the treatment of non-small cell lung cancer. This combination therapy is currently in Phase III clinical trials.

In summary, Mirati Therapeutics is a biotech company that operates in the oncology market, developing innovative treatments for cancer. The company generates revenue from the sales of these treatments to healthcare providers.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 2013
Outcome tier
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Mirati Therapeutics in the San Diego ecosystem

Live from Dealroom

The Mirati Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Team profiled 19 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown
Web traffic by country
990 monthly visits
across markets
🇺🇸 United States222.2%
🏳️ Russian Federation50.5%
🇲🇦 Morocco0%
Top 3 markets shown

Patents

Estimated portfolio value
$108M

99 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Mirati Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Mirati Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.